Legislative Affairs

“One of the penalties of not participating in politics is that you will be governed by your inferiors.”

Plato

The mission of APCI’s Legislative Affairs division is to promote and protect the political and economic interests of all APCI members. In order to accomplish that mission, Legislative Affairs:

  • Provides lobbyist and/or legislative assistance in all APCI member states
  • Identifies pharmacy-friendly political candidates and generate funding to support them
  • Contributes to state associations and organizations with similar legislative focus
  • Identifies political leaders to meet and key meetings or conferences to attend
  • Establishes routine and structured legislative meetings in each state
  • Leverages APCI account representatives and staff personnel
  • Utilizes APCI's Board of Directors to attend selected legislative events
  • Encourages APCI member participation and support of NCPA
  • Maintains a Washington, D.C., presence, supporting NCPA and developing direct relationships

For more information about APCI's Legistative Affairs division, contact us or call (800) 532-2724.

13

Jan

2015

Call to action regarding Aetna and Medicare Part D

Confusion continues to surround Aetna’s Part D networks for 2015 with the greatest concern now the lack of timely access to critical medications, especially among the most frail and susceptible Medicare beneficiaries.

15

Dec

2014

Alliance of Independent Pharmacists of Texas and APCI announce advocacy partnership

Alliance of Independent Pharmacists of Texas and APCI announce advocacy partnership

The Alliance of Independent Pharmacists of Texas and APCI today announced the two entities have entered into a partnership. This new legislative and advocacy collaboration will further unify independent pharmacy in Texas and enable APCI members to have a stronger voice at the state’s Capitol.

8

Dec

2014

NCPA Advocacy Center Update: Week ending Dec. 6

Lots of news on the community pharmacy advocacy front this week, including mail order requirements, track and trace guidance, Part D lock-in programs, and more.

24

Nov

2014

CMS Delays Federal Upper Limits Again

The Centers for Medicare & Medicaid Services (CMS) announced plans to delay the Federal Upper Limits (FUL) and the Final Rule on Covered Outpatient Drugs… again.

21

Nov

2014

U.S. Senate committee holds hearing on generic pricing [LINKS]

Recent price spikes for what were up until recently low-cost generic drugs prompted a Senate committee to look into the issue.


First 76777879 Last